Lucía Fernandez-Romero , James Carrick , Ramon Landin-Romero , David Foxe , Miguel Yus-Fuertes , Alberto Marcos-Dolado , Jordi A. Matias-Guiu , Olivier Piguet
{"title":"Cognitive profiles in primary progressive aphasia variants: A cross-cultural Australian and Spanish investigation","authors":"Lucía Fernandez-Romero , James Carrick , Ramon Landin-Romero , David Foxe , Miguel Yus-Fuertes , Alberto Marcos-Dolado , Jordi A. Matias-Guiu , Olivier Piguet","doi":"10.1016/j.jns.2025.123446","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The effect of cultural differences in neurodegenerative diseases is not well understood. We aimed to investigate the cognitive profiles of English- and Spanish-speaking individuals with primary progressive aphasia (PPA).</div></div><div><h3>Methodology</h3><div>A comparative cross-sectional study was conducted with 461 participants: 215 participants from Australia and 246 from Spain. The Australian cohort included 131 PPA patients: 37 nonfluent PPA (nfvPPA), 49 semantic PPA (svPPA), 45 logopenic (lvPPA) and 84 healthy controls (HC); the Spanish cohort had 162 PPA: 64 nfvPPA, 31 vsPPA, 67 lvPPA, and 84 HC. All participants completed the ACE-III and other tests assessing verbal working memory, attention/executive functioning, visuospatial constructional abilities and episodic memory. A subgroup of participants underwent structural brain MRI. Cognitive performance and neuroimaging were compared between groups.</div></div><div><h3>Results</h3><div>The most salient differences between each variant and HC were similar in the Australian and Spanish cohort. However, the Spanish cohort scored lower than the Australian cohort in most cognitive tests evaluated (ACE-III total, attention, memory and visuospatial in nfvPPA; attention, memory, and visuospatial in svPPA; and memory, language, and visuospatial in lvPPA). Differences were particularly pronounced in the visuospatial subdomain among nonfluent variant PPA. Cortical thickness analysis showed the expected regional atrophy in each PPA variant, but with no greater atrophy in the Spanish cohort.</div></div><div><h3>Conclusion</h3><div>These findings revealed an impairment in other cognitive domains beyond language in PPA. However, Spanish patients exhibited more generalized cognitive involvement despite similar demographic and neuroimaging profiles, suggesting that cultural and resilience factors may influence PPA presentations.</div></div>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"472 ","pages":"Article 123446"},"PeriodicalIF":3.6000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Neurological Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022510X25000632","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The effect of cultural differences in neurodegenerative diseases is not well understood. We aimed to investigate the cognitive profiles of English- and Spanish-speaking individuals with primary progressive aphasia (PPA).
Methodology
A comparative cross-sectional study was conducted with 461 participants: 215 participants from Australia and 246 from Spain. The Australian cohort included 131 PPA patients: 37 nonfluent PPA (nfvPPA), 49 semantic PPA (svPPA), 45 logopenic (lvPPA) and 84 healthy controls (HC); the Spanish cohort had 162 PPA: 64 nfvPPA, 31 vsPPA, 67 lvPPA, and 84 HC. All participants completed the ACE-III and other tests assessing verbal working memory, attention/executive functioning, visuospatial constructional abilities and episodic memory. A subgroup of participants underwent structural brain MRI. Cognitive performance and neuroimaging were compared between groups.
Results
The most salient differences between each variant and HC were similar in the Australian and Spanish cohort. However, the Spanish cohort scored lower than the Australian cohort in most cognitive tests evaluated (ACE-III total, attention, memory and visuospatial in nfvPPA; attention, memory, and visuospatial in svPPA; and memory, language, and visuospatial in lvPPA). Differences were particularly pronounced in the visuospatial subdomain among nonfluent variant PPA. Cortical thickness analysis showed the expected regional atrophy in each PPA variant, but with no greater atrophy in the Spanish cohort.
Conclusion
These findings revealed an impairment in other cognitive domains beyond language in PPA. However, Spanish patients exhibited more generalized cognitive involvement despite similar demographic and neuroimaging profiles, suggesting that cultural and resilience factors may influence PPA presentations.
期刊介绍:
The Journal of the Neurological Sciences provides a medium for the prompt publication of original articles in neurology and neuroscience from around the world. JNS places special emphasis on articles that: 1) provide guidance to clinicians around the world (Best Practices, Global Neurology); 2) report cutting-edge science related to neurology (Basic and Translational Sciences); 3) educate readers about relevant and practical clinical outcomes in neurology (Outcomes Research); and 4) summarize or editorialize the current state of the literature (Reviews, Commentaries, and Editorials).
JNS accepts most types of manuscripts for consideration including original research papers, short communications, reviews, book reviews, letters to the Editor, opinions and editorials. Topics considered will be from neurology-related fields that are of interest to practicing physicians around the world. Examples include neuromuscular diseases, demyelination, atrophies, dementia, neoplasms, infections, epilepsies, disturbances of consciousness, stroke and cerebral circulation, growth and development, plasticity and intermediary metabolism.